120 related articles for article (PubMed ID: 7625467)
21. Increased left posterior parietal-temporal cortex activation after D-fenfluramine in women with panic disorder.
Meyer JH; Swinson R; Kennedy SH; Houle S; Brown GM
Psychiatry Res; 2000 May; 98(3):133-43. PubMed ID: 10821996
[TBL] [Abstract][Full Text] [Related]
22. Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers.
Aluoja A; Shlik J; Vasar V; Kingisepp PH; Jagomägi K; Vasar E; Bradwejn J
Psychiatry Res; 1997 Jan; 66(1):59-67. PubMed ID: 9061804
[TBL] [Abstract][Full Text] [Related]
23. Global cerebral blood flow during infusion of adenosine in humans: assessment by magnetic resonance imaging and positron emission tomography.
Stånge K; Greitz D; Ingvar M; Hindmarsh T; Sollevi A
Acta Physiol Scand; 1997 Jun; 160(2):117-22. PubMed ID: 9208037
[TBL] [Abstract][Full Text] [Related]
24. Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans.
Leicht G; Mulert C; Eser D; Sämann PG; Ertl M; Laenger A; Karch S; Pogarell O; Meindl T; Czisch M; Rupprecht R
Biol Psychiatry; 2013 Feb; 73(4):337-44. PubMed ID: 23059050
[TBL] [Abstract][Full Text] [Related]
25. Cerebral blood flow measurements by magnetic resonance imaging bolus tracking: comparison with [(15)O]H2O positron emission tomography in humans.
Ostergaard L; Johannsen P; Høst-Poulsen P; Vestergaard-Poulsen P; Asboe H; Gee AD; Hansen SB; Cold GE; Gjedde A; Gyldensted C
J Cereb Blood Flow Metab; 1998 Sep; 18(9):935-40. PubMed ID: 9740096
[TBL] [Abstract][Full Text] [Related]
26. Responses to hypercarbia induced by acetazolamide in panic disorder patients.
Mathew RJ; Wilson WH; Tant S
Am J Psychiatry; 1989 Aug; 146(8):996-1000. PubMed ID: 2750998
[TBL] [Abstract][Full Text] [Related]
27. The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity.
Carhart-Harris RL; Murphy K; Leech R; Erritzoe D; Wall MB; Ferguson B; Williams LT; Roseman L; Brugger S; De Meer I; Tanner M; Tyacke R; Wolff K; Sethi A; Bloomfield MA; Williams TM; Bolstridge M; Stewart L; Morgan C; Newbould RD; Feilding A; Curran HV; Nutt DJ
Biol Psychiatry; 2015 Oct; 78(8):554-62. PubMed ID: 24495461
[TBL] [Abstract][Full Text] [Related]
28. Prediction of panic response to a respiratory stimulant by reduced orbitofrontal cerebral blood flow in panic disorder.
Kent JM; Coplan JD; Mawlawi O; Martinez JM; Browne ST; Slifstein M; Martinez D; Abi-Dargham A; Laruelle M; Gorman JM
Am J Psychiatry; 2005 Jul; 162(7):1379-81. PubMed ID: 15994724
[TBL] [Abstract][Full Text] [Related]
29. Cerebral blood flow changes in limbic regions induced by unsolvable anagram tasks.
Schneider F; Gur RE; Alavi A; Seligman ME; Mozley LH; Smith RJ; Mozley PD; Gur RC
Am J Psychiatry; 1996 Feb; 153(2):206-12. PubMed ID: 8561200
[TBL] [Abstract][Full Text] [Related]
30. Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers.
Koszycki D; Cox BJ; Bradwejn J
Am J Psychiatry; 1993 Dec; 150(12):1881-3. PubMed ID: 8238648
[TBL] [Abstract][Full Text] [Related]
31. Effects of cannabidiol (CBD) on regional cerebral blood flow.
Crippa JA; Zuardi AW; Garrido GE; Wichert-Ana L; Guarnieri R; Ferrari L; Azevedo-Marques PM; Hallak JE; McGuire PK; Filho Busatto G
Neuropsychopharmacology; 2004 Feb; 29(2):417-26. PubMed ID: 14583744
[TBL] [Abstract][Full Text] [Related]
32. The ventilatory response to cholecystokinin tetrapeptide in healthy volunteers.
Katzman MA; Duffin J; Shlik J; Bradwejn J
Neuropsychopharmacology; 2002 Jun; 26(6):824-31. PubMed ID: 12007753
[TBL] [Abstract][Full Text] [Related]
33. Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder.
Ströhle A; Kellner M; Holsboer F; Wiedemann K
Am J Psychiatry; 2001 Sep; 158(9):1514-6. PubMed ID: 11532742
[TBL] [Abstract][Full Text] [Related]
34. Marijuana intoxication and brain activation in marijuana smokers.
Mathew RJ; Wilson WH; Coleman RE; Turkington TG; DeGrado TR
Life Sci; 1997; 60(23):2075-89. PubMed ID: 9180362
[TBL] [Abstract][Full Text] [Related]
35. Dose ranging study of the effects of cholecystokinin in healthy volunteers.
Bradwejn J; Koszycki D; Bourin M
J Psychiatry Neurosci; 1991 Jul; 16(2):91-5. PubMed ID: 1911739
[TBL] [Abstract][Full Text] [Related]
36. Quantitative comparison of the bolus and steady-state methods for measurement of cerebral perfusion and oxygen metabolism: positron emission tomography study using 15O-gas and water.
Okazawa H; Yamauchi H; Sugimoto K; Takahashi M; Toyoda H; Kishibe Y; Shio H
J Cereb Blood Flow Metab; 2001 Jul; 21(7):793-803. PubMed ID: 11435791
[TBL] [Abstract][Full Text] [Related]
37. Behavioral and cerebrovascular effects of caffeine in patients with anxiety disorders.
Mathew RJ; Wilson WH
Acta Psychiatr Scand; 1990 Jul; 82(1):17-22. PubMed ID: 2399815
[TBL] [Abstract][Full Text] [Related]
38. Cerebral blood flow changes during vagus nerve stimulation for depression.
Conway CR; Sheline YI; Chibnall JT; George MS; Fletcher JW; Mintun MA
Psychiatry Res; 2006 Mar; 146(2):179-84. PubMed ID: 16510266
[TBL] [Abstract][Full Text] [Related]
39. The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation.
Rauch SL; Savage CR; Alpert NM; Fischman AJ; Jenike MA
Biol Psychiatry; 1997 Sep; 42(6):446-52. PubMed ID: 9285080
[TBL] [Abstract][Full Text] [Related]
40. The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms.
Le Mellédo JM; Bradwejn J; Koszycki D; Bichet DG; Bellavance F
Biol Psychiatry; 1998 Sep; 44(5):364-6. PubMed ID: 9755359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
